DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China · Delayed Price · Currency is CNY 19.22
-0.28 (-1.44%)
Feb 13, 2026, 3:00 PM CST
32.92% (1Y)
| Market Cap | 21.89B +41.3% |
| Revenue (ttm) | 26.83B +1.1% |
| Net Income | 1.14B +33.8% |
| EPS | 1.01 +35.1% |
| Shares Out | 1.14B |
| PE Ratio | 19.00 |
| Forward PE | 17.47 |
| Dividend | 0.68 (3.49%) |
| Ex-Dividend Date | Nov 6, 2025 |
| Volume | 6,004,543 |
| Average Volume | 7,950,939 |
| Open | 19.55 |
| Previous Close | 19.50 |
| Day's Range | 19.17 - 19.99 |
| 52-Week Range | 14.39 - 21.78 |
| Beta | 0.66 |
| RSI | 48.34 |
| Earnings Date | Apr 24, 2026 |